HtrA2-mediated RIP1 cleavage regulates neuronal inflammation and death

HtrA2介导的RIP1裂解调节神经元炎症和死亡

基本信息

  • 批准号:
    9371476
  • 负责人:
  • 金额:
    $ 22.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

5. Project Summary/Abstract The goals of this proposal are to define the molecular mechanisms by which HtrA2-mediated cleavage of RIP1 regulates inflammation and cell death in striatal neurons in response to TNF and oxidative stress, and to assess the pathological relevance of upstream and downstream effectors of RIP1 (i.e. TNF and RIP3) in the onset and progression of basal ganglia disorder in HtrA2-mutant (Mnd2; motor neuron degeneration 2) mice. TNF and oxidative stress are significant underlying factors for many neurodegenerative diseases, and identification of the key molecular events that control neuronal response to TNF and oxidative stress are an important and urgent task for the development of novel diagnostic approaches and therapeutic strategies. RIP1 is a dual-function (adaptor and kinase) protein that plays a key role in TNF- and oxidative stress-induced cell survival, apoptosis and necroptosis. The ability of RIP1 to modulate cell survival is largely controlled by its K63- linked ubiquitination and NF-B activation, and the prodeath function of it is dependent on its kinase activity. It is known that RIP1 overexpression promotes both NF-B activation and cell death; however, the post-translational regulation of RIP1 protein abundance under basal and chronic stress conditions is largely unknown. HtrA2 is a serine protease and has been shown to promote cell death by degrading anti-apoptotic XIAP and cIAP1/2 proteins; however, gene knockout (KO) studies reveal that HtrA2 KO mice exhibit neurodegenerative disorder characteristic of Parkinson’s disease (PD), and that HtrA2 KO cells display significantly increased susceptibility to stress-induced apoptosis and necrosis. Notably, Mnd2 mice exhibit the same phenotype with HtrA2 KO mice, and were found to carry a missense mutation in the protease domain of HtrA2 gene. Mutations in human HTRA2 gene have also been found in sporadic PD patients, suggesting that HtrA2 enzymatic activity is required for the suppression of inflammation and neuronal death. However, the substrate(s) responsible for PD-like phenotype in Mnd2 mice have not yet been identified. We found that RIP1 is cleaved by HtrA2 in hematopoietic and brain tissues of wild-type (WT) but not of Mnd2 mice. Importantly, knockdown of RIP1 in Mnd2 and HtrA2 KO cells significantly suppressed the susceptibility of these cells to cellular stresses. Given that RIP1 overexpression is known to cause NF-B activation and cell death, we hypothesize that HtrA2-mediated cleavage of RIP1 limits its proinflammatory and prodeath functions to maintain the homeostasis of organ/tissues that are sensitive to RIP1 protein abundance, and that altered regulation of this process under conditions of chronic stresses could lead to RIP1-mediated inflammation and neurodegeneration. To test these hypotheses, we propose to carry out the following specific aims: Aim-1. Define the mechanisms by which RIP1 triggers inflammation and neuronal death in the striatum of Mnd2 mice; Aim-2. Assess the pathological relevance of TNF and RIP3 in the development of PD-like disease in Mnd2 mice. Thus the completion of this project has the potential to guide the development of novel approaches for the therapy of neurodegenerative disease through the intervention of RIP1 cleavage.
5.项目总结/摘要 本提案的目的是确定HtrA 2介导的RIP 1裂解的分子机制 调节纹状体神经元对TNF α和氧化应激反应的炎症和细胞死亡, 评估RIP 1的上游和下游效应物(即TNF α和RIP 3)在 在HtrA 2突变体(Mnd 2;运动神经元变性2)小鼠中基底神经节病症的发作和进展。 TNF α和氧化应激是许多神经退行性疾病的重要潜在因素, 确定控制神经元对TNF α和氧化应激反应的关键分子事件是一项重要的研究。 这是发展新的诊断方法和治疗策略的重要而紧迫的任务。RIP1 是一种双功能(衔接子和激酶)蛋白,在TNF α和氧化应激诱导细胞中起关键作用 存活、凋亡和坏死性凋亡。RIP 1调节细胞存活的能力在很大程度上受其K63- 它与泛素化和NF-κ B B活化有关,其促死亡功能依赖于其激酶活性。是 已知RIP 1过表达促进NF-κ B B活化和细胞死亡;然而, 在基础和慢性应激条件下RIP 1蛋白丰度的调节在很大程度上是未知的。HtrA 2是一种 丝氨酸蛋白酶,并已显示通过降解抗凋亡XIAP和cIAP 1/2促进细胞死亡 然而,基因敲除(KO)研究表明,HtrA 2 KO小鼠表现出神经退行性疾病, 帕金森病(PD)的特征,并且HtrA 2 KO细胞显示出显著增加的易感性 应激诱导的细胞凋亡和坏死。值得注意的是,Mnd 2小鼠表现出与HtrA 2 KO小鼠相同的表型, 并被发现在HtrA 2基因的蛋白酶结构域中携带错义突变。人类HTRA 2突变 在散发性PD患者中也发现了HtrA 2基因,这表明HtrA 2酶活性是PD治疗所必需的。 抑制炎症和神经元死亡。然而,在PD样表型中负责PD样表型的底物在PD样表型中是不稳定的。 mnd 2小鼠尚未被鉴定。我们发现RIP 1在造血和脑组织中被HtrA 2切割, 野生型(WT)但Mnd 2小鼠的组织。重要的是,Mnd 2和HtrA 2 KO细胞中RIP 1的敲低 显著抑制了这些细胞对细胞应激的敏感性。考虑到RIP 1过表达是 已知引起NF-κ B B活化和细胞死亡,我们假设HtrA 2介导的RIP 1切割限制了其表达。 促炎和促死亡功能,以维持对RIP 1敏感的器官/组织的稳态 蛋白质丰度,并且在慢性应激条件下改变这一过程的调节可能导致 RIP 1介导的炎症和神经变性。为了验证这些假设,我们建议进行 具体目标如下:目标1。定义RIP 1触发炎症和神经元死亡的机制 在Mnd 2小鼠的纹状体中; Aim-2.评估TNF α和RIP 3在肿瘤发生中的病理相关性。 Mnd 2小鼠中的PD样疾病。因此,该项目的完成有可能指导 通过干预RIP 1裂解治疗神经变性疾病的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HASEM HABELHAH其他文献

HASEM HABELHAH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HASEM HABELHAH', 18)}}的其他基金

The roles of TRAF2 and RIP1 in breast cancer cell survival
TRAF2 和 RIP1 在乳腺癌细胞存活中的作用
  • 批准号:
    10363270
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
The roles of TRAF2 and RIP1 in breast cancer cell survival
TRAF2 和 RIP1 在乳腺癌细胞存活中的作用
  • 批准号:
    10619506
  • 财政年份:
    2022
  • 资助金额:
    $ 22.88万
  • 项目类别:
Therapeutic efficacies of neutrophil elastase and RIP1 inhibitors in acute lung injury
中性粒细胞弹性蛋白酶和RIP1抑制剂治疗急性肺损伤的疗效
  • 批准号:
    10311120
  • 财政年份:
    2020
  • 资助金额:
    $ 22.88万
  • 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 裂解 RIP1 对于 TRAIL 诱导的 NF-kB 激活至关重要
  • 批准号:
    8033152
  • 财政年份:
    2010
  • 资助金额:
    $ 22.88万
  • 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 对 RIP1 的切割对于 TRAIL 诱导的 NF-kB 激活至关重要
  • 批准号:
    8403529
  • 财政年份:
    2010
  • 资助金额:
    $ 22.88万
  • 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 裂解 RIP1 对于 TRAIL 诱导的 NF-kB 激活至关重要
  • 批准号:
    7887290
  • 财政年份:
    2010
  • 资助金额:
    $ 22.88万
  • 项目类别:
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation
Caspase-8 裂解 RIP1 对于 TRAIL 诱导的 NF-kB 激活至关重要
  • 批准号:
    8206767
  • 财政年份:
    2010
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of TRAF2 Activity in Normal and Tumor Cells
正常细胞和肿瘤细胞中 TRAF2 活性的调节
  • 批准号:
    7339874
  • 财政年份:
    2006
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of TRAF2 Activity in Normal and Tumor Cells
正常细胞和肿瘤细胞中 TRAF2 活性的调节
  • 批准号:
    7187428
  • 财政年份:
    2006
  • 资助金额:
    $ 22.88万
  • 项目类别:
Regulation of TRAF2 Activity in Normal and Tumor Cells
正常细胞和肿瘤细胞中 TRAF2 活性的调节
  • 批准号:
    7034445
  • 财政年份:
    2006
  • 资助金额:
    $ 22.88万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10596657
  • 财政年份:
    2021
  • 资助金额:
    $ 22.88万
  • 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10417219
  • 财政年份:
    2021
  • 资助金额:
    $ 22.88万
  • 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 22.88万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
  • 批准号:
    nhmrc : 1059331
  • 财政年份:
    2014
  • 资助金额:
    $ 22.88万
  • 项目类别:
    Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 22.88万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 22.88万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
  • 批准号:
    251802
  • 财政年份:
    2012
  • 资助金额:
    $ 22.88万
  • 项目类别:
    Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
  • 批准号:
    191299
  • 财政年份:
    2009
  • 资助金额:
    $ 22.88万
  • 项目类别:
    Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    8075522
  • 财政年份:
    2009
  • 资助金额:
    $ 22.88万
  • 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    7676912
  • 财政年份:
    2009
  • 资助金额:
    $ 22.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了